Sycale Advisors (Ny) LLC Chroma Dex Corp. Transaction History

Sycale Advisors (Ny) LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 03, 2021	SELL	$4.59 - $18.74 $3.28 Million - $13.4 Million	-714,404 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$3.93 - $5.5 $560,811 - $784,850	142,700 Added 24.96%	714,404 $3.43 Million
Q3 2020 Nov 12, 2020	BUY	$4.01 - $5.56 $849,951 - $1.18 Million	211,958 Added 58.92%	571,704 $2.29 Million
Q2 2020 Jul 28, 2020	BUY	$3.0 - $5.52 $134,163 - $246,859	44,721 Added 14.2%	359,746 $1.65 Million
Q4 2019 May 07, 2020	BUY	$2.83 - $4.61 $891,520 - $1.45 Million	315,025 New	315,025 $1.36 Million

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $386M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Sycale Advisors (Ny) LLC, based on Form 13F filings with the SEC.

Stay updated on Sycale Advisors (Ny) LLC with notifications on news.